Intracranial Hemorrhages: Clinical Trials

180 trials for Intracranial Hemorrhages, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

82 completed, 31 unknown, 23 recruiting, 18 terminated. 180 Phase 2, 30 Phase 1, 27 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 2180Completed 82, Unknown 31, Recruiting 23, Terminated 18, Withdrawn 10, Not yet recruiting 9, Active not recruiting 5, Enrolling by invitation 1, Suspended 1
Phase 130Completed 15, Unknown 8, Not yet recruiting 2, Withdrawn 2, Active not recruiting 1, Recruiting 1, Terminated 1
Phase 327Completed 11, Unknown 7, Recruiting 4, Terminated 3, Not yet recruiting 1, Withdrawn 1

Follow Intracranial Hemorrhages: new trials by email Literature Review of Intracranial Hemorrhages trials Research Report on Intracranial Hemorrhages

Trials (filtered) newest first · largest first

All 180 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ventricular mTOR Inhibition to Prevent Hydrocephalus After Brain Hemorrhage
Sirolimus (Rapamune®) - Post-hemorrhagic Hydrocephalus (PHH)
Phase 1 / Phase 2Not yet recruitingMassachusetts General Hospital152027-01-012026-06-25
Induced Suppression of Platelet Activity in Aneurysmal Subarachnoid Hemorrhage Management-2 (iSPASM-2)
Tirofiban, Placebo - Aneurysmal Subarachnoid Hemorrhage
Phase 1 / Phase 2Not yet recruitingDr David Hasan, M.D.822026-12-052026-11-04
MMA Infusion of Lidocaine for Treatment of Headache in Patients With Aneurysmal SAH
Lidocaine hydrochloride, Isotonic saline - Headaches Associated With Subarachnoid Hemorrhage (SAH)
Phase 2Not yet recruitingCopenhagen University Hospital, Rigshospitalet902026-12-012026-09-11
IA Lidocaine and Methylprednisolone for Headache Associated With Subarachnoid Hemorrhage
Lidocaine hydrochloride, Methylprednisolone sodium succinate - Headaches Associated With Subarachnoid Hemorrhage (SAH)
Phase 2RecruitingDaniel Raper, MBBS252026-06-232026-07-08
GLP-1 Receptor Agonist in Primary Intracerebral Hemorrhage: A Phase 2 Randomized Trial
Semaglutide, 0.5 mg/mL - Intracerebral Hemorrhage
Phase 2Not yet recruitingChinese University of Hong Kong2002026-06-152026-05-29
Role of Neuroinflammation and Blood-Brain Barrier Breakdown in Intracerebral Hemorrhage.
TEP with 18F-DPA-714 injection - Intracerebral Hemorrhage
Phase 2Not yet recruitingUniversity Hospital, Toulouse1172026-06-012026-05-13
Synergistic Minimally Invasive Surgery and Deferoxamine in ICH
Minimally Invasive surgery (MIS), Deferoxamine, Standard Medical Care (SMD) - Intracerebral Hemorrhage, ICH - Intracerebral Hemorrhage
Phase 2 / Phase 3Not yet recruitingUniversity of Illinois at Chicago2402026-03-012025-10-10
Minocycline in Stroke Study at Maimonides
Minocycline 200mg - Stroke, Ischemia Stroke
Phase 2 / Phase 3RecruitingJoyce Chen11642026-02-022026-03-19
Infusion of Lidocaine and Steroids in Middle Meningeal Artery for Pain in Subarachnoid Hemorrhage
Lidocaine, Lidocaine and Dexamethasone - Subarachnoid Hemorrhage, Aneurysmal, Headache
Phase 2RecruitingThe University of Texas Medical Branch, Galveston152026-01-022026-11-03
Adjuvant Tranexamic Acid (TXA) Versus Surgery Alone for Adult Patients With Chronic Subdural Hematoma (CSDH)
Tranexamic Acid (Cyklokapron) - Chronic Subdural Hematoma
Phase 2 / Phase 3RecruitingSt. Olavs Hospital2742025-12-102026-07-17
Clinical Study to Evaluate the Efficacy of Febuxostat in the Treatment of Conservatively Managed Intracranial Hemorrhage Patients
Febuxostat 40 mg, Standard medical treatment - Intracranial Hemorrhage
Phase 2RecruitingTanta University462025-11-202026-07-15
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial on the Treatment of Hypertensive Intracerebral Hemorrhage With Naoxuekang Dropping Pills
Naoxuekang Dropping Pills, Naoxuekang Matching Placebo - Hypertensive Intracerebral Hemorrhage, Cerebral Small Vessel Diseases
Phase 2Not yet recruitingBeijing Tiantan Hospital19502025-10-102025-10-01
Tranexamic Acid Therapy For The Treatment of Subdural Hematomas
Tranexamic Acid 650 MG, Placebo - Chronic Subdural Hematoma
Phase 2Not yet recruitingBaylor College of Medicine2402025-10-012025-05-14
Efficacy of Daily IV Administration of Dornase Alfa up to 14 Days Post Subarachnoid Hemorrhage on Functional Independence at 6 Months
Daily infusion of dornase alfa - Ruptured Aneurysm of Intracranial Artery, SAH (Subarachnoid Hemorrhage)
Phase 2RecruitingFondation Ophtalmologique Adolphe de Rothschild3042025-09-262026-05-08
Intra-Arterial Tenecteplase Following Endovascular Thrombectomy for Large Vessel Occlusion Stroke
Intra-arterial Tenecteplase, Intra-arterial Saline - Acute Ischemic Stroke
Phase 2Enrolling by invitationWake Forest University Health Sciences402025-09-222026-09-25
FLudrocortisone Administration in Aneurysmal Subarachnoid Haemorrhage
Fludrocortisone, Placebo - Aneurysmal Subarachnoid Hemorrhage
Phase 2RecruitingThe George Institute5242025-08-132025-12-16
Colchicine for the Prevention of Recurrence in Cerebral Amyloid Angiopathy RElated IntraCerebral Hemorrhage
Colchicine 0.5mg, Matching placebo - Cerebral Amyloid Angiopathy, Intracerebral Hemorrhage Lobar
Phase 2RecruitingHuashan Hospital802025-06-182025-06-26
Effect of Cilostazol in Promoting Hematoma Clearance After Intracerebral Hemorrhage
Pletaal 100mg/tab, Conventional internal medicine treatment - ICH - Intracerebral Hemorrhage
Phase 2RecruitingNational Taiwan University Hospital1002025-06-162026-03-09
Stem Cell Therapy for Intracerebral Hemorrhage
Device: Phase Ⅰ Dose Level 1, Device: Phase Ⅰ Dose Level 2, Device: Phase Ⅰ Dose Level 3 - Intracerebral Hemorrhage, Mesenchymal Stem Cell
Phase 1 / Phase 2RecruitingTang Zhouping392025-06-022026-10-20
Effect of Xenon on Brain Injury After Aneurysmal Subarachnoid Hemorrhage
Xenon, air/oxygen - Subarachnoid Hemorrhage, Aneurysmal, Cerebral Injury
Phase 2RecruitingTurku University Hospital1602025-04-222025-05-01

Showing 20 of 180. Sign in to see all of them.

Narrower conditions

Cerebral Hemorrhage (76)  ·  Subarachnoid Hemorrhage (74)  ·  Stroke (33)  ·  Vasospasm, Intracranial (16)  ·  Ischemic Stroke (13)  ·  Hematoma, Subdural, Chronic (12)  ·  Aneurysm (11)  ·  Intracranial Aneurysm (9)  ·  Hemorrhagic Stroke (8)  ·  Brain Injuries, Traumatic (7)  ·  Brain Ischemia (6)  ·  Cerebrovascular Disorders (6)  ·  Hemorrhage (6)  ·  Headache (5)

Broader conditions

Pathologic Processes (178)  ·  Pathological Conditions, Signs and Symptoms (178)  ·  Vascular Diseases (178)  ·  Brain Diseases (177)  ·  Cardiovascular Diseases (177)  ·  Central Nervous System Diseases (177)  ·  Nervous System Diseases (177)  ·  Cerebrovascular Disorders (174)  ·  Hemorrhage (172)  ·  Wounds and Injuries (25)  ·  Trauma, Nervous System (22)  ·  Craniocerebral Trauma (21)  ·  Signs and Symptoms (19)  ·  Intracranial Hemorrhage, Traumatic (16)

Interventions

Sodium Chloride (13)  ·  Saline Solution (12)  ·  Tranexamic Acid (12)  ·  Deferoxamine (6)  ·  Dexamethasone (5)  ·  Tissue Plasminogen Activator (5)  ·  Propofol (4)  ·  Simvastatin (4)  ·  Fentanyl (3)  ·  Labetalol (3)  ·  Lidocaine (3)  ·  Magnesium Sulfate (3)  ·  Minocycline (3)  ·  Nimodipine (3)  ·  Sirolimus (3)

Sponsors

Beijing Tiantan Hospital (5)  ·  Novo Nordisk A/S (4)  ·  Capital Medical University (3)  ·  Chinese University of Hong Kong (3)  ·  Johns Hopkins University (3)  ·  Oslo University Hospital (3)  ·  Tang-Du Hospital (3)  ·  Thomas Jefferson University (3)  ·  University Hospital Heidelberg (3)  ·  University of Florida (3)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (2)  ·  Beth Israel Deaconess Medical Center (2)  ·  Henry Ford Health System (2)  ·  Hope Biosciences LLC (2)  ·  Hope Pharmaceuticals (2)

Countries

United States (63)  ·  China (28)  ·  Canada (24)  ·  Germany (12)  ·  Netherlands (10)  ·  United Kingdom (10)  ·  Finland (8)  ·  Australia (6)  ·  Egypt (5)  ·  France (5)  ·  Italy (5)  ·  Switzerland (5)  ·  Taiwan (4)  ·  Denmark (3)  ·  Norway (3)

Top investigators

Sven Poli, Dr. med. (3)  ·  Charles S Cox, MD (2)  ·  Dimitre Staykov, MD (2)  ·  George KC Wong (2)  ·  Magdy Selim, MD, PhD (2)  ·  Michael D Hill, MD (2)  ·  Michael Diringer, MD (2)  ·  Peter J Kirkpatrick, FRCS(SN) (2)  ·  Susanne Muehlschlegel, MD (2)  ·  Adam Burgoyne, MD, PhD (1)  ·  Aditya Pandey, MD (1)  ·  Adrian Parry-Jones, PhD, MRCP (1)  ·  Alejandro Rabinstein, MD (1)  ·  Alex Nesbitt, MBBS (1)

Results publications

PMID 37870112, PMID 31424491, PMID 36700520, PMID 41114449, PMID 11105983, PMID 11161595, PMID 11590206, PMID 14671250, PMID 15569871, PMID 15728810, PMID 16179504, PMID 16319269, PMID 16552014, PMID 16636233, PMID 16757825, PMID 17038942, PMID 17290026, PMID 17630481, PMID 18211362, PMID 18239180, PMID 18289410, PMID 18420953, PMID 18580208, PMID 18658043, PMID 18676556, PMID 19061352, PMID 19197830, PMID 19344224, PMID 19628806, PMID 19762703, PMID 20536619, PMID 20798370, PMID 21346218, PMID 21396235, PMID 21454813, PMID 21998061, PMID 22282887, PMID 22678087, PMID 22747768, PMID 22776958, PMID 23228346, PMID 23391776, PMID 23392270, PMID 23551657, PMID 23581590, PMID 23636409, PMID 23680226, PMID 23706046, PMID 23943316, PMID 23981692

NIH funding

2014 (2), 2017 (2), U01NS074425 (2), 2004 (1), 2005 (1), 2015 (1), 2019 (1), 2023 (1), 2025 (1), P50NS044227 (1), P50NS044283 (1), R01AG069930 (1), R01NS038484 (1), R01NS046309 (1), R44NS063485 (1)